Building Quan

A trio of Chinese biopharma veterans is taking advantage of a growing domestic biotech industry and a wave of innovation-friendly regulatory and policy reforms to establish Quan Capital Management LLC, a global VC that could help healthcare companies on both sides of the Pacific navigate the China market.

Its inaugural fund, Quan Venture Fund L.P., closed at about $150 million in August and will invest in 10 to 15 companies. ...